Innov'nCare

Innov’nCare is a deeptech startup developing a next-generation therapeutic vectorization platform. Its mission: to enable the precise delivery of treatments to stem cells — including cancer stem cells — to enhance therapeutic efficacy and long-term outcomes.

Innov’nCare was co-founded by two scientists with complementary backgrounds: Claire Lépinoux-Chambaud, PhD in Neuroscience and co-author of the patent protecting the developed technology, and Clément Sanchez, PhD in Medicinal Chemistry. Together, they bring cross-disciplinary expertise in medicinal chemistry, cell biology, pharmaceutical and pharmacological development, and analytical sciences. They are jointly developing a unique platform capable of selectively delivering therapeutic agents to stem cells, the most resistant and critical cell populations in a wide range of diseases, particularly cancers.

This breakthrough opens new avenues for targeted and personalized therapies, while minimizing side effects.